Association analysis of drug metabolizing enzyme gene polymorphisms in AIDS patients with cutaneous reactions to sulfonamides

J Invest Dermatol. 2005 Nov;125(5):1080-2. doi: 10.1111/j.0022-202X.2005.23939.x.

Authors

Pierre Wolkenstein, Marie-Anne Loriot, Antoine Flahault, Michel Cadilhac, Eric Caumes, Muriel Eliaszewicz, Philippe Beaune, Jean-Claude Roujeau, Olivier Chosidow; Epitox Group

PMID: 16297214
DOI: 10.1111/j.0022-202X.2005.23939.x

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Acquired Immunodeficiency Syndrome / complications*
Acquired Immunodeficiency Syndrome / enzymology
Acquired Immunodeficiency Syndrome / genetics
Adult
Anti-Infective Agents / adverse effects*
Aryl Hydrocarbon Hydroxylases / genetics*
Cytochrome P-450 CYP2C9
Drug Hypersensitivity / etiology
Drug Hypersensitivity / genetics*
Female
Glutathione S-Transferase pi / genetics*
Humans
Inactivation, Metabolic / genetics
Male
Polymorphism, Genetic*
Skin / immunology
Sulfonamides / adverse effects*

Substances

Anti-Infective Agents
Sulfonamides
CYP2C9 protein, human
Cytochrome P-450 CYP2C9
Aryl Hydrocarbon Hydroxylases
GSTP1 protein, human
Glutathione S-Transferase pi